uniQure N.V. ( QURE) - Key Metrics
QURE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.09 | -$1.22 | -$0.43 | -$0.44 |
| 2026Q1 | $0.06 | -$0.85 | -$0.61 | -$0.61 |
| 2025Q4 | $0.10 | -$0.64 | -$1.35 | -$1.34 |
| 2025Q3 | $0.06 | -$1.38 | -$0.28 | -$0.28 |
| 2025Q2 | $0.10 | -$0.69 | -$0.73 | -$0.73 |
QURE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -9.44 |
| 2026Q1 | 0% | -4.81 |
| 2025Q4 | 0% | -10.14 |
| 2025Q3 | 0% | -10.57 |
| 2025Q2 | 0% | -5.05 |
QURE
Price: $44.50
52 week price:
Earnings Per Share: -4.06 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Netherlands
Volume: 380100
Ebitda: -8.2 millionMarket Capitalization: 3.2 billion